| Literature DB >> 12360145 |
Syed A Sattar1, V Susan Springthorpe, Jason Tetro, Robert Vashon, Bruce Keswick.
Abstract
Enteric and respiratory viruses are among the most frequent causes of human infections, and hands play an important role in the spread of these and many other viral diseases. Regular and proper hand hygiene by caregivers and food handlers in particular is essential to decontaminate hands and potentially interrupt such spread. What would be considered a proper decontamination of hands? Handwashing with regular soap and water is often considered sufficient, but what of hygienic handwash and handrub antiseptic products? Are they more effective? The evidence suggests that some clearly are. Activity against bacteria may not reflect the ability of hygienic hand antiseptics to deal with viruses, especially those that are nonenveloped. In spite of the acknowledged importance of hands as vehicles for viruses, there is a lack of suitable regulatory mechanism for handwash or handrub products to make claims of efficacy against viruses. This is in contrast with the ability of general-purpose disinfectants to make antiviral claims, although transmission of viruses from surfaces other than those of reusable medical devices may play only a minor role in virus transmission. This review discusses the (1). recent information on the relative importance of viruses as human pathogens, particularly those causing enteric and respiratory infections; (2). the survival of relevant viruses on human hands in comparison with common gram-negative and gram-positive bacteria; (3). the potential of hands to transfer or receive such contamination on casual contact; (4). role of hands in the spread of viruses; (5). the potential of hygienic measures to eliminate viruses from contaminated hands; (6). relative merits of available protocols to assess the activity of hygienic hand antiseptics against viruses; and (7). factors considered crucial in any tests to assess the activity of hygienic hand antiseptics against viruses. In addition, this review proposes surrogate viruses in such testing and discusses issues for additional consideration by researchers, manufacturers, end-users, and regulators.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12360145 PMCID: PMC7172183 DOI: 10.1067/mic.2002.124532
Source DB: PubMed Journal: Am J Infect Control ISSN: 0196-6553 Impact factor: 2.918
Fig. 2Survival of selected viruses and bacteria on the fingerpads of adult subjects 1 hour after experimental contamination.114, 115
Basic characteristics of viruses causing respiratory, enteric, eye, skin, and other infections in humans
| Virus (# of types) | Size and shape | Genome | Envelope | Association with disease |
|---|---|---|---|---|
| Adenoviruses (>47) | 70-90 nm, icosahedral | Double-stranded, linear DNA | No | Fever, rhinitis, pharyngitis, laryngitis, bronchiolitis, tonsillitis, cough, pneumonia, and conjunctivitis. Types 40, 41 can cause acute gastroenteritis. |
| Astroviruses (>2) | 27-30 nm, icosahedral | Single-stranded, positive-sense RNA | No | Acute gastroenteritis |
| Coronaviruses (3) | 120-160 nm, pleomorphic | Single stranded, Linear, positive-sense RNA | Yes | Common colds and perhaps gastroenteritis |
| Cytomegalovirus (1) | 150 nm diameter with an iscosahedral core | Double-stranded, linear DNA | Yes | |
| Enteroviruses (>70) | 27-30 nm, icosahedral | Single-stranded, positive-sense RNA | No | Gastroenteritis, myocarditis, skin rash, meningitis, encephalitis, and polio-like paralysis |
| Hepatitis A virus (1) | 27-30 nm, icosahedral | Single-stranded, positive-sense RNA | No | Infectious hepatitis |
| Herpesviruses (>8) | 150 nm diameter with an iscosahedral core | Double-stranded, linear DNA | Yes | Sores on lips, genital area, fingers, eyes as well as chicken pox; cervical cancer Kaposi's sarcoma, encephalitis, and meningitis |
| Influenzaviruses (3) | 100 nm diameter with helical symmetry | Single-stranded, segmented RNA | Yes | Influenza and pneumonia |
| Norwalk and related viruses (>6) | 27-32 nm, round | Single-stranded, positive-sense RNA | No | Acute gastroenteritis |
| Papillomaviruses (>60) | 40-55 nm, icosahedral | Circular, double-stranded DNA | No | Warts, laryngeal papillomas, cervical cancer |
| Poxviruses (>10) | 230-400 nm with a complex structure | Double-stranded DNA | Yes | Vesicles and pustules on skin |
| Respiratory syncytial virus (1) | 150-300 nm, pleomorphic | Single-stranded, negative-sense, segmented RNA | Yes | Bronchiolitis and pneumonia among infants, children under 1 y of age and the elderly |
| Rhinoviruses (>100) | 27 nm, icosahedral | Single-stranded, positive sense RNA | No | Most frequent cause of the common cold |
| Rotaviruses (>6) | 60-80 nm, icosahedral | Double stranded, segmented RNA | No | Severe diarrhea among children, mild gastrointestinal illness in adults |
Estimates of the annual incidence of URTIs in the United States*
| Etiologic agent | % Illness caused by each agent | No. illnesses caused by each agent per 10,000 population | % Illnesses with consultation | No. illnesses with consultation per 10,000 population |
|---|---|---|---|---|
| Rhinoviruses | 34 | 8325 | 17.6 | 1465 |
| Coronaviruses | 14 | 3428 | 17.6 | 603 |
| Influenzaviruses | 9 | 2204 | 37.9 | 835 |
| Parainfluenzaviruses | 4 | 979 | 26.2 | 257 |
| Respiratory syncytial virus | 4 | 979 | 55.6 | 544 |
| Adenoviruses | 2 | 490 | 43.2 | 212 |
| Other viruses | 2 | 490 | 27.8 | 136 |
| Subtotal | 69 | 16,895 | 4052 | |
| Bacterial | 8 | 1959 | 48.6 | 952 |
| Unknown agents or noninfectious | 23 | 5630 | 21.5 | 1211 |
| Total | 100 | 24,484 | 6215 | |
| *Adapted from | ||||
Effect of respiratory tract infections in the elderly
| Etiologic agent(s) | % Cases | |
|---|---|---|
| Nicholson et al | Greenberg et al | |
| Rhinoviruses | 52 | 23 |
| Coronaviruses | 26 | 23 |
| Influenzaviruses | 10 | 12 |
| Respiratory syncytial virus | 7 | 12 |
| Parainfluenzaviruses | 3 | 29 |
| Adenoviruses | 0.5 | 0.02 |
| Subtotal | 98.5 | 99.02 |
| Others (chlamydia and mycoplasma pneumoniae) | 1.5 | Not tested |
| Total | 100 | 99.02 |
Relative strengths and weaknesses of methods available to assess the virus-eliminating activity of hygienic hand antiseptics
| Test protocol | Comments |
|---|---|
| Suspension tests | Suspension tests |
| Inanimate carriers | Although the use of inanimate carriers with dried inocula represents a more stringent challenge to the formulation being tested, |
| Whole-hand method | Field application of hygienic hand antiseptics can be best simulated in a properly designed whole-hand method, |
| Fingertip method | Although a smaller inoculum volume (20 μL) is placed on each fingertip in this method, |
| Fingerpad method | This method, |
| Ex vivo tests with human skin | In vivo methods may not be unsuitable when testing experimental actives and high-risk viruses such as HIV and ex vivo protocols based on human skin are possible alternatives. |
| Animal skin | Human skin is unique in the thickness of its stratum corneum, density of hair follicles and the nature of its sweat glands. |
| Other substrates as carriers | Human cadaveric skin, collagen membranes, cultured corneal fibroblasts, |
Important factors in assessing hygienic hand antiseptics against viruses
| Test virus(es) to be used | Test viruses should be selected carefully for their safety to human subjects, ease of cultivation and quantitation, ability to survive on human skin, relative resistance to chemical germicides, and relevance to spread by hands. The use of 1 or more carefully selected viruses as surrogates is highly recommended. |
| Infectivity assay of test virus(es) | Use of animals should be avoided in such tests and cell culture systems with optimal susceptibility to the test virus(es) are considered ideal. As far as possible, indirect measures of virus infectivity (eg, assaying for viral enzymes) should also be avoided. |
| Human subjects to be selected for testing | Proper permissions must be obtained before the recruitment of human subjects, and everyone selected must be judged suitable on the basis of standard inclusion and exclusion criteria. Written informed consent must also be obtained from each subject before participation. |
| Nature and level of soil loading | The presence of a soil load in the virus suspension is considered important to present the test formulation to reflect the fact that in nature viruses are always associated with cellular debris and organic and inorganic substances. The soil load selected must be shown to be harmless to the test virus(es). |
| Diluent, if required, for the test product | If the test product needs dilution in water before use, and unless some other diluent is to be specified on the product label, water with a standardized (eg, 200 parts per million as CaCO3) level of hardness is recommended. Use of tap water should be avoided in such tests because of wide variations in the quality of tap water both geographically and temporally. |
| Time used for the initial drying of the inoculum | The virus inoculum must be visibly dry before exposure to the test formulations, but over-drying can lead to excessive losses in virus infectivity. Staggering of the inoculation of the carriers and their randomization would be desirable to increase the level of confidence in the data generated. |
| Contact between virus and germicide | Contact time should not be longer than 10-20 sec to keep it relevant to the field use of such products. |
| Neutralization of virucidal activity | Virucidal activity of test formulation must be arrested effectively and immediately at the end of the contact time for a meaningful interpretation of the test data. Any neutralizer selected for the purpose must be shown to be safe for the virus and noncytotoxic for the host cells. Dilution of the virus-germicide mixture at the end to the contact time is often the simplest and “universal” means of arresting the germicidal activity when working with hygienic hand antiseptics. |
| Procedure for the elimination of cytotoxicity | All eluates and their dilutions must be free from cytotoxicity before any measurement of virus infectivity. Gel-filtration or centrifugation inevitably increases contact time between virus and test germicide. |
| No. test and control subjects | No. of repeats may be dictated by the requirements of the target regulatory agency. However, we believe that no more than 3-6 subjects would be sufficient to demonstrate the activity of a given formulation against the test virus selected. In this regard, the fingerpad method provides for enough digits in any given test to include the necessary controls as well as 2-4 replicates for tests on the hands of the same subject. |
| Product lots to be tested | At least 2 product lots must be tested and found to give similar results. |
| Product performance criterion | Currently, no guidelines are available in this regard. However, the limitations of working with viruses in general and to keep the product performance criteria in line with the levels of viral contamination expected on hands under field situations, a 2 to 3 log10 reduction in virus infectivity after exposure to the test product should be considered a reasonable level of performance. |
| Essential controls | Need for a host system in working with viruses increases the variety of controls beyond those needed in bactericidal tests. For example, controls must be included to ensure that any non-cytotoxic residue of the test germicide is not interfering with the ability of the virus to infect the host cells. |
Viruses relevant in hand antisepsis and possible surrogates for testing activity against viruses
| Virus | In vitro infectivity assay method | Safe for skin | Survival on hands | Potential for spread by hands | Suitability as a surrogate | Comments |
|---|---|---|---|---|---|---|
| Adenoviruses | Yes | Yes | Good | Yes | Yes | Many types of adenoviruses are safe and relatively easy to work with in the laboratory; however, they may be less resistant to chemical germicides than other nonenveloped viruses, such as hepatitis A and rotaviruses. |
| Norwalk virus | No | Yes | Unknown | Very high | No | Human caliciviruses cannot be grown in the laboratory, but some animal types, such as feline caliciviruses, can be cultured and could act as surrogates for the Norwalk virus. |
| Hepatitis A virus | Yes | Yes | Very good | Very high | Possible | Relatively resistant to inactivation by many germicides used as topicals; vaccination of personnel handling the virus is recommended. |
| Herpesviruses | Yes | No | Poor | High | No | Fragile viruses with low resistance to many chemicals |
| Papillomaviruses | No | No | Unknown | High | No | Human papillomaviruses cannot be grown in the laboratory, whereas some animal papillomaviruses may be cultured and quantitated with some difficulty; papovaviruses such as simian virus 40 (SV40) as possible surrogates. |
| Enteroviruses (Coxsackie, echo, polioviruses, and other members) | Yes | Yes | Good | Not known | Possible | Although the vaccine strains of polioviruses are safe, the use of all polioviruses will soon be phased out in view of the anticipated eradication of poliomyelitis; whereas a coxsackie- or echovirus may be used instead, their safety will be a concern. |
| Poxviruses | Yes | No | Yes | Unknown | No | Generally difficult to work with in the laboratory and also require specialized facilities for handling and containment except for vaccinia virus. |
| Influenza-viruses | Yes | Yes | Very poor | Unknown | No | Fragile viruses with low resistance to many chemicals. |
| Respiratory syncytial virus | Yes | Yes | Very poor | High | No | Fragile viruses with low resistance to many chemicals. |
| Rhinoviruses | Yes | Yes | Very good | High | Yes | Relatively safe and easy viruses to work with in the laboratory. |
| Rotaviruses | Yes | Yes | Very good | Very high | Yes | Relatively safe and easy viruses to work with in the laboratory. |